Streetbeat News

MEDS

TRxADE HEALTH, Inc.

https://www.trxadehealth.com

Industry

Medical - Pharmaceuticals

TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.

Open

7.25

Mkt cap

13M

Volume

19K

High

7.70

P/E Ratio

-0.31

52-wk high

44.56

Low

7.06

Div yield

1.25

52-wk low

3.69

TRxADE HEALTH, Inc. (NASDAQ:MEDS) announced a special cash dividend of $8 per share, funded by the sale of its web-based market platform assets. The dividend is payable to stockholders of record as of March 18, with payment on March 22. Following the announcement, MEDS shares surged 82.5% to $15.20, with trading volume exceeding 4.11 million shares, significantly above the 100-day average of less than 232,000 shares.

Portfolio Pulse from Erica Kollmann

March 06, 2024 | 5:00 pm

U.S. stocks traded higher with the Nasdaq Composite gaining over 100 points. Energy shares jumped by 1.2% as U.S. crude oil inventories climbed less than expected. Aptorum Group, TRxADE HEALTH, and American Public Education saw significant gains, while Entravision Communications, Neptune Wellness Solutions, and Foot Locker experienced sharp declines. Oil prices rose 2.7% to $80.26, and gold increased by 0.6%.

Portfolio Pulse from Avi Kapoor

March 06, 2024 | 4:57 pm

Box, Inc. reported better-than-expected fourth-quarter EPS and announced a $100 million expansion of its stock repurchase program, leading to a 7.3% rise in its shares. Other companies like TRxADE HEALTH, American Public Education, and Dada Nexus also saw significant gains following positive financial results or announcements. Notably, MicroStrategy's shares rose 10% after a previous day's 21% drop due to a proposed convertible senior notes offering.

Portfolio Pulse from Avi Kapoor

March 06, 2024 | 4:45 pm

TRxADE Health announced a special cash dividend of $8 per share, causing its shares to trade higher.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 1:35 pm

CrowdStrike Holdings (CRWD) shares surged 27% after reporting better-than-expected Q4 earnings and revenues, with positive guidance for Q1 and FY25, leading to raised price targets by analysts. Creative Medical Technology Holdings, Inc. (CELZ) saw an 85% increase after receiving FDA Orphan Drug Designation for CELZ-101. TRxADE Health, Inc. (MEDS) announced a special cash dividend of $8/share, resulting in a 67% stock price increase.

Portfolio Pulse from ryanfaloona@benzinga.com

March 06, 2024 | 1:33 pm

TRxADE Health, Inc. has declared a special cash dividend of $8 per share, a significant return to its shareholders. This move could indicate strong financial health or a strategy to return excess cash to shareholders.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 1:06 pm

In Wednesday's pre-market session, several healthcare stocks showed significant movement. Inspire Veterinary, Motus GI Holdings, and Talphera were among the top gainers, with notable increases in their stock prices. Conversely, Avinger, Biofrontera, and Teladoc Health were among the top losers, experiencing significant declines. NeoGenomics and Teladoc Health released their Q4 earnings, impacting their stock prices.

Portfolio Pulse from Benzinga Insights

February 21, 2024 | 1:06 pm

U.S. stocks traded lower with the Nasdaq Composite down over 200 points. Consumer staples shares rose by 1.2%, while information technology shares fell by 1.8%. The Conference Board's Leading Economic Index fell 0.4% for January. Monopar Therapeutics, Biofrontera, and TRxADE HEALTH saw significant stock increases due to positive company news. Conversely, RAPT Therapeutics, Summit Therapeutics, and Fluor Corporation experienced notable declines following negative developments.

Portfolio Pulse from Avi Kapoor

February 20, 2024 | 7:33 pm

Fluor Corporation's shares fell by 7.7% following its Q4 results, with earnings beating estimates but sales missing expectations. Other stocks moved significantly in Tuesday's session, with notable gainers including TRxADE HEALTH, AgriFORCE Growing Systems, and Monopar Therapeutics, among others, due to various positive announcements. Losers included RAPT Therapeutics, MicroCloud Hologram, and Summit Therapeutics, primarily due to negative news or disappointing results.

Portfolio Pulse from Avi Kapoor

February 20, 2024 | 6:21 pm

In Tuesday's intraday session, several healthcare stocks experienced significant movements. Monopar Therapeutics led the gainers with a 138.8% increase, while RAPT Therapeutics saw the largest decline at 66.2%. Other notable movers include Trxade Health, Biofrontera, Iovance Biotherapeutics, and SeaStar Medical Holding among the gainers, and Summit Therapeutics, Better Therapeutics, Universe Pharmaceuticals, Sientra, and Tenaya Therapeutics among the losers.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 5:31 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.